Pro Data Export
Sucampo Pharmaceuticals Key Statistics
Current Valuation
Dividends and Shares
| Shares Outstanding | 41.97M |
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Latest Dividend Date | |
| Latest Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin Quarterly | 70.97% |
| Profit Margin Quarterly | 38.82% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 2.319 |
| Debt to Equity Ratio | 1.228 |
| Free Cash Flow | 17.04M |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | 40.53% |
| Year to Date Stock Returns | 93.88% |
| 1 Year Stock Returns | 18.75% |
| 3 Year Stock Returns | 157.5% |
| 52 Week High | 10.48 |
| 52 Week Low | 3.78 |
Income Statement
Cash Flow Statement
| Cash from Financing TTM | -8.446M |
| Cash from Investing TTM | -0.589M |
| Cash from Operations TTM | 12.00M |
| Capital Expenditures Quarterly Pro | Go Pro |
Balance Sheet
| Cash and ST Investments | 58.06M |
| Long Term Debt | 52.85M |
| Total Assets | 127.80M |
| Liabilities | 84.77M |
| Shareholders Equity | 43.03M |
| Book Value | 43.03M |
| Book Value Per Share | 1.025 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
SCMP News
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SCMP | 9.50 | +0.04 | +0.42% | 398.67M |
New watchlist
